Skip to content

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

Pilot Study of Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02726763
Enrollment
18
Registered
2016-04-04
Start date
2016-03-30
Completion date
2027-03-01
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Survivors

Keywords

Transcranial Direct Current Stimulation (tDCS), Cognitive Training, 16-034

Brief summary

In this study, the investigators are testing transcranial direct current stimulation (tDCS) in breast cancer survivors. In this pilot study, the investigators want to learn if it is feasible to use this device in memory rehabilitation.

Interventions

DEVICETranscranial Direct Current Stimulation (tDCS)
BEHAVIORALQuestionnaires

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Breast cancer survivors treated with chemotherapy between 40 and 65 years of age with no evidence of disease with treatment completed at least six months prior to study participation with or without current endocrine therapy. * Self-reported new onset since initiation of treatment cognitive dysfunction as determined by telephone screen using the brief (3 questions) assessment established by Ercoli et al. \[3\] (endorsement on all three questions): 1. Do you think or feel that your memory or mental ability has gotten worse since you completed your breast cancer treatment? 2. Do you think that your mind isn't as sharp now as it was before your breast cancer treatments? 3. Do you feel like these problems have made it harder to function on your job or take care of things around the home? * In the judgment of the investigators and/or consenting professional, able to read and comprehend English * In the judgment of the consenting professional cognitively able to provide informed consent

Exclusion criteria

* Patients with prior history of primary Central Nervous System (CNS) cancer or CNS metastases * As per self report and/or medical record history of diagnosed neurological illness including seizure disorder, a dementing condition, or other neurological illness (multiple sclerosis, history of cerebrovascular accident, etc.) * Participants with untreated depression or anxiety as assessed by self-report and review of medical history; * Participants with a history of treated or untreated schizophrenia or bipolar disorder as assessed by self report and review of medical history; * As per self report participants who are pregnant or who are breastfeeding * As per self report participants with pacemakers, intracranial electrodes, implanted defibrillators or any other prosthesis.

Design outcomes

Primary

MeasureTime frameDescription
number of subjects recruited6 monthsfeasibility defined by the number of subjects recruited in a six month time frame

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJames Root, PhD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026